Maureen E. Trudeau MA, MD, FRCPC, Chair of the Clinical Advisory Board

Head, division of medical oncology/hematology, Sunnybrook Health Sciences Centre, Head, systemic therapy program, Odette Cancer Centre, Professor, department of medicine, faculty of medicine, University of Toronto, Co-chair, breast cancer site group, Cancer Care Ontario.Dr. Trudeau is one of Canada’s leading breast cancer research clinical scientists and practicing breast cancer specialists. She was the Principal Investigator on the pivotal MA.22 clinical trial which led to the discovery of RDA and is committed to working with the company to turn RDA into a widely used clinical tool.

Gunter von Minckwitz, MD, PhD, Clinical Advisory Board Member

Chairman of the German Breast Group (GBG) Research Institute. GBG is the largest cooperative group in Germany working in the field of breast cancer with approximately 530 centres, 1100 collaborators and an annual recruitment of over 4000 breast cancer patients into prospective clinical trials. He is also a Professor and Senior Physician at the Centre of Gynaecology and Obstetrics, University of Frankfurt, Germany.

Professor von Minckwitz has authored and co-authored over 115 Medline listed scientific papers, in addition to 450 review articles, book chapters and printed abstracts, as well as 15 books. He is on the board of directors of the Breast International Group (BIG), and became member of the St. Gallen Consensus Panel in 2008.

Michael Untch, MD, PhD, Clinical Advisory Board Member

Head, Clinic for Gynecology, Gynecologic Oncology, and Obstetrics, Head, Breast interdisciplinary Cancer Center Department of Obstetrics and Gynecology, Helios Klinikum Berlin-Buch, Germany, Head, German Breast Group. Dr. Untch is one of the foremost experts in the field of neoadjuvant chemotherapy in breast cancer. He has published extensively on neoadjuvant chemotherapy treatment in breast cancer and is a recognized international thought leader in breast cancer treatment. Dr. Untch works very closely with Dr. von Minckwitz.

Harry D. Bear, M.D., Ph.D.

Lawrence Professor of Oncology, Chairman, Division of Surgical Oncology, Virginia Commonwealth University, Massey  Cancer Center. Member, NSABP Foundation Board of Directors. Dr. Bear received the Distinguished Investigator Lifetime Achievement Award from the NSABP Foundation, Inc. During the past two decades, Bear, a researcher and surgeon, has led international trials that have resulted in major changes in the treatment of breast cancer and dramatically increased the chance for breast onservation among women with breast cancer. The NSABP is a national cooperative group that develops and conducts clinical studies to
improve treatments and outcomes for breast and colorectal cancers. Its acronym stands for the National Surgical Adjuvant Breast and Bowel Project.